Robert Saltmarsh, Nick Venuto | GenomeWeb
Nanogen said last week that CFO Robert Saltmarsh will retire at the end of February 2008. He will be succeeded by Nick Venuto, who currently serves as executive director of finance. Saltmarsh will continue to consult for the company through 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.